So it would be important for Parliament to follow this important issue in the next few months, and even over the next few years.
I would like to come back very quickly to another issue. I am very pleased to learn that there is good cooperation between Health Canada and your international colleagues. We were just talking earlier about the Sandoz issue. In that case, we saw that the FDA was the first to identify the problem.
Let's go back to what Mr. Allen said earlier, with respect to the number of times where the report points out that the problems were detected by international agencies. I am very pleased to learn that you are able to work with those agencies.
However, we need to think about our "medical sovereignty", if you'll pardon the somewhat ridiculous term. Don't you think it's important for Health Canada to be able to identify the problems on its own, without being taken hostage by other authorities in Europe or the United States?